Key result
Community cardiometabolic screening links male sex to ~85% higher odds of hypertension.
Why the study?
Community screening may identify unrecognised cardiometabolic risk outside routine healthcare, though screening datasets often contain incomplete measurements. The study aimed to describe cardiometabolic risk factors detected by a community screening programme and identify independent predictors of hypertension and dysglycaemia.
Does a community cardiometabolic screening programme identify a substantial burden and independent predictors of unrecognized hypertension and dysglycaemia in adults outside routine healthcare contacts?
Cross-Sectional (n=356)
Yes
Does a community cardiometabolic screening programme identify a substantial burden and independent predictors of unrecognized hypertension and dysglycaemia in adults outside routine healthcare contacts?
Community screening in Slovakia uncovered a substantial hidden burden of elevated blood pressure (39.7%) and dysglycaemia (14.0%) among adults not previously managed for these conditions, supporting community-based screening paired with structured follow-up.
May inform targeted community screening; leaves open generalizability and need for prospective validation of predictors.
Objectives: To describe cardiometabolic risk factors detected by a community screening programme and to identify independent predictors of hypertension and dysglycaemia. Background: Community screening may identify persons with unrecognised cardiometabolic risk outside routine healthcare contacts. Screening datasets often contain incomplete measurements. Methods: We analysed anonymised cross-sectional data from 356 participants of the Zdravie na dosah project. Measurements included blood pressure, anthropometry, capillary glycaemia and point-of-care lipid profile. Hypertension was defined as blood pressure at least 140/90 mmHg and dysglycaemia as random capillary glycaemia at least 7.8 mmol/L. Logistic regression with multiple imputation was used. Results: Median age was 47 years (interquartile range 37-62) and median body mass index was 26.0 kg/m2 (22.4-29.4). Hypertension was present in 39.7% of participants with measured blood pressure and dysglycaemia in 14.0% with measured glycaemia. In imputed models, hypertension was independently associated with age (odds ratio 1.03 per year, p=0.002) and male sex (odds ratio 1.85, p=0.016). Dysglycaemia was independently associated with age (odds ratio 1.03, p=0.017). Conclusion: Community screening identified hidden burden of elevated blood pressure and dysglycaemia. Structured follow-up after screening may support earlier prevention of cardiometabolic complications.
No takes yet. Share an insight, caveat, or question.
Kalavská et al. (2026) conducted a cross-sectional in Cardiometabolic risk (hypertension and dysglycaemia) (n=356). Male sex (and age in community cardiometabolic screening) vs. Female sex was evaluated on Hypertension (blood pressure >=140/90 mmHg) (OR 1.85, 95% CI 1.12-3.05, p=0.0156). Community cardiometabolic screening detected hypertension in 39.7% and dysglycaemia in 14.0% of participants, with hypertension independently associated with male sex (OR 1.85) and age (OR 1.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: